Evidence for functional 5-HT2 receptor sites on human blood platelets.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Biochemical Pharmacology

• Publication date

  1984-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0006-2952(84)90699-3PMID 6466388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonparametric Statistics for the Behavioral Sciences

  2022cited by this paper
• TWO KINDS OF TRYPTAMINE RECEPTOR

  1997cited by this paper
• The involvement of 5-HT2-receptor sites in the activation of cat platelets.

  1984cited by this paper
• Further evidence that vascular serotonin receptors are of the 5HT2 type.

  1983cited by this paper
• Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserin.

  1983cited by this paper
• 5-hydroxytryptamine and platelet aggregation.

  1983cited by this paper
• Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist

  1982cited by this paper
• Functional distinction between serotonin uptake and serotonin-induced shape change receptors in rat platelets.

  1982cited by this paper
• [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

  1982cited by this paper
• Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro.

  1981cited by this paper
• Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle.

  1981cited by this paper
• Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.

  1981cited by this paper
• Human platelet 5HT receptors: characterisation and functional association.

  1980cited by this paper
• Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation.

  1979cited by this paper
• Novel α2-adrenoreceptors primarily responsible for inducing human platelet aggregation

  1979cited by this paper
• Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.

  1979cited by this paper
• Platelet Malonyldialdehyde Formation: An Indicator of Platelet Hyperfunction

  1979cited by this paper
• Simple, sensitive fluorimetric assay for malondialdehyde production by blood platelets.

  1977cited by this paper
• The lumi-aggregometer: a new instrument for simultaneous measurement of secretion and aggregation by platelets.

  1977cited by this paper
• Inhibition of platelet aggregation induced by either epinephrine or arachidonic acid.

  1975cited by this paper
• The Effect of pH on Human Platelet Aggregation Induced by Epinephrine and ADP 1

  1972cited by this paper
• D-Receptor for Serotonin on Blood Platelets

  1969cited by this paper
• Applied Regression Analysis.

  1967cited by this paper

• Genomic resources from the Yunnan–Guizhou Plateau reveal the linguistic‐linked demographic history and insights into human adaptation and disease of multi‐ancestry populations

  2025cites this paper
• Monoaminergic Modulation of Learning and Cognitive Function in the Prefrontal Cortex

  2024cites this paper
• Derrone Inhibits Platelet Aggregation, Granule Secretion, Thromboxane A2 Generation, and Clot Retraction: An In Vitro Study

  2021cites this paper
• Molecular insights into psychedelic drug action

  2021cites this paper
• Serotonin 2A receptors and cannabinoids.

  2021cites this paper
• Serotonergic Receptor 5-HT 2A in the Cardiosympathovagal System

  2018cites this paper
• Mechanisms of platelet inhibition by the selective serotonin reuptake inhibitor citalopram

  2018cites this paper
• Development and evaluation of a medicated chewing gum containing Sceletium tortuosum

  2018cites this paper
• Class A GPCR: Serotonin Receptors

  2017cites this paper
• Hypertension artérielle pulmonaire, moelle osseuse, précurseurs endothéliaux et sérotonine

  2016cites this paper
• Genomic structure and expression of the human serotonin 2A receptor gene (HTR2A) locus: identification of novel HTR2A and antisense (HTR2A-AS1) exons

  2016cites this paper
• [Pulmonary arterial hypertension, bone marrow, endothelial cell precursors and serotonin].

  2016cites this paper
• Platelets in Alzheimer’s Disease

  2015cites this paper
• Effects of ketanserin on microcirculatory alterations in septic shock: An open-label pilot study.

  2015cites this paper
• UvA-DARE ( Digital Academic Repository ) Microcirculatory dysfunction in critically ill patients : prevalence and significance from a bedside perspective

  2014influential citation
• Alzheimer and platelets: low-density platelet populations reveal increased serotonin content in Alzheimer type dementia.

  2014cites this paper
• HETEROGENEITY IN PLATELET EXOCYTOSIS

  2013cites this paper
• On platelet biology and cardiovascular disease

  2013cites this paper
• Citalopram is a more potent platelet function inhibitor than paroxetine in a case–control study

  2012cites this paper
• Platelets at work in primary hemostasis.

  2011cites this paper
• Genetic Modifiers of Caffeine Consumption and Risk of Myocardial Infarction

  2011cites this paper
• Fluoxetine inhibition of 5-HT-potentiated platelet aggregation in whole blood

  2010cites this paper
• Measurement of collagen- and serotonin-induced platelet aggregation in whole blood

  2010cites this paper
• Platelets and Cardiac Arrhythmia

  2010cites this paper
• A study on the effects of serotonin reuptake inhibitors on platelet function in whole blood and platelet concentrates

  2010cites this paper
• α1-acid glycoprotein modulates the function of human neutrophils and platelets

  2009cites this paper
• Role of cytosolic calcium and actin polymerization on agonist-induced secretion by the platelets of liver cirrhosis patients.

  2009cites this paper
• Identification of 5-HT3 receptors on human platelets: Increased surface immunoreactivity after activation with adenosine diphosphate (ADP) and thrombin receptor-activating peptide (TRAP)

  2008cites this paper
• The Role of Chlamydia pneumoniae-induced Platelet Activation in Cardiovascular Disease : In vitro and In vivo studies

  2007cites this paper
• The metabolism of serotonin in neuronal cells in culture and platelets

  2007cites this paper
• Risperidona y acontecimientos adversos cerebrovasculares en los pacientes ancianos con demencia

  2006cites this paper
• 5-hydroxytryptamine receptors in the human cardiovascular system.

  2006cites this paper
• [Risperidone and cerebrovascular adverse effects in elderly patients with dementia].

  2006cites this paper
• SPONTANEOUS FRACTURES OF LONG BONES ASSOCIATED WITH JOINT CONTRACTURES IN BEDRIDDEN ELDERLY INPATIENTS: CLINICAL FEATURES AND OUTCOME

  2005cites this paper
• Chronic naltrexone suppresses platelet aggregation induced by adrenaline and 5-hydroxytryptamine in former heroin addicts

  2005cites this paper
• ASSOCIATION BETWEEN RISPERIDONE TREATMENT AND CEREBROVASCULAR ADVERSE EVENTS IN ELDERLY PATIENTS WITH DEMENTIA

  2005cites this paper
• Involvement of 5-HT 2 Receptors in Chronic Endothelial Dysfunction After Balloon Injury of Porcine Coronary Arteries

  2005cites this paper
• RISK OF ACQUIRING INFLUENZA B IN A NURSING HOME FROM A CULTURE‐POSITIVE ROOMMATE

  2005cites this paper
• ENTEROCOCCAL ENDOCARDITIS PRESENTING WITH SUDDEN RIGHT ARM WEAKNESS IN A 73‐YEAR‐OLD MAN

  2005cites this paper
• Pharmacokinetics of ketanserin in patients with essential hypertension

  2004cites this paper
• Central serotonin receptors: effector systems, physiological roles and regulation

  2004cites this paper
• In vitro effects of risperidone and 9-hydroxy-risperidone on human platelet function, plasma coagulation, and fibrinolysis.

  2004cites this paper
• Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro

  2003cites this paper
• Concurrent responses elicited by isolated activation of platelet G q -coupled receptors, in vitro : a novel approach for their separation and analysis

  2003cites this paper
• Diversity of signaling underlying responses mediated by selective activation of the platelet thromboxane A2 (TXA2) receptor; pharmacological and kinetic studies in vitro.

  2003cites this paper
• SEROTONINSKI SUSTAV U TROMBOCITIMA ZDRAVIH LJUDI

  2003cites this paper
• Second messengers in platelet aggregation evoked by serotonin and A23187, a calcium ionophore.

  2001cites this paper
• Binding affinity of a newly synthesized 5-HT2 antagonist, AT-1015 (N-[2-[4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-piperidino]ethyl]-1-formyl-4-piperidinecarboxamide monohydrochloride monohydrate), in the rabbit platelet membrane.

  2001cites this paper
• Antiplatelet and Antithrombotic Activity of SL65.0472, a Mixed 5-HT1B/5-HT2A Receptor Antagonist

  2001cites this paper
• Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.

  2001cites this paper
• Activation of the 2A –adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro

  2001cites this paper
• Endocrine Responses after d-Fenfluramineand Ipsapirone Challenge: Further Support for Cloninger’s Tridimensional Model of Personality

  2000cites this paper
• AT-1015, a novel serotonin (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2A receptors and prevents the laurate-induced peripheral vascular lesion in rats.

  2000cites this paper
• Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Preserves Coronary Flow Reserve During Progressive Coronary Arteriostenosis in Swine

  2000cites this paper
• Platelet dense granules: structure, function and implications for haemostasis.

  1999cites this paper
• Relationship between central and peripheral serotonin 5-HT2A receptors: a positron emission tomography study in healthy individuals.

  1999cites this paper
• PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907.

  1998cites this paper
• Characteristics of agonist displacement of [3H]ketanserin binding to platelet 5-HT2A receptors: implications for psychiatric research.

  1998cites this paper
• Elevated [3H]inositol 1,4,5-trisphosphate binding sites and expressed inositol 1,4,5-trisphosphate receptor protein level in platelets of depressed patients

  1998cites this paper
• Serotonin 5-HT2A receptors: molecular biology and mechanisms of regulation.

  1998cites this paper
• [3H]Ketanserin Binding in Human Brain Postmortem

  1997cites this paper
• Effects of serotonin on platelet activation in whole blood

  1997cites this paper
• A Naturally Occurring Amino Acid Substitution of the Human Serotonin 5‐HT2A Receptor Influences Amplitude and Timing of Intracellular Calcium Mobilization

  1997cites this paper
• γ-Mangostin, a novel type of 5-hydroxytryptamine 2A receptor antagonist

  1997cites this paper
• Modulation of platelet function and vascular smooth muscle contractile actions by a novel, selective, highly potent 5-HT2 antagonist (SR46349).

  1996cites this paper
• Biochemical profile of YM992, a novel selective serotonin reuptake inhibitor with 5-HT2A receptor antagonistic activity.

  1996cites this paper
• The potentiation of adrenaline-induced in vitro platelet aggregation by ADP, collagen and serotonin and its inhibition by naftopidil and doxazosin in normal human subjects.

  1995cites this paper
• Phosphoinositide system-linked serotonin receptor subtypes and their pharmacological properties and clinical correlates.

  1995cites this paper
• Effect of ketanserin on platelet function and bleeding time in uremic patients treated with erythropoietin.

  1995cites this paper
• Characterization of the human 5-HT2A receptor gene promoter

  1995cites this paper
• The role of serotonin blockers in cardiac anesthesia.

  1994cites this paper
• Comparative effects of anti‐platelet agents as adjuncts to tissue plasminogen activator in a dog model of occlusive coronary thrombosis

  1994cites this paper
• Platelet [3H]paroxetine binding, 5-HT-stimulated Ca2+ response, and 5-HT content in winter seasonal affective disorder.

  1994cites this paper
• The relationship of platelet 5-HT2 receptor indices to major depressive disorder, personality traits, and suicidal behavior.

  1994cites this paper
• The role of serotonin 5HT2 receptor antagonism in the control of coronary artery disease.

  1994cites this paper
• Involvement of 5-HT2 receptors in chronic endothelial dysfunction after balloon injury of porcine coronary arteries.

  1994cites this paper
• In search of black bile: do antidepressants act by changing endogenous endocoids in the depressed patient?

  1993cites this paper
• 5HT2-receptors and serotonin release: their role in human platelet aggregation.

  1993cites this paper
• Antithrombotic Activity of SR 46349, a Novel, Potent and Selective 5-HT2 Receptor Antagonist

  1993cites this paper
• Interaction between the effects of 5‐hydroxytryptamine and adrenaline on the growth of platelet thrombi in the coronary artery of the anaesthetized dog

  1993cites this paper
• Serotonin2 receptor binding in blood platelets of schizophrenic patients.

  1993cites this paper
• Virus‐induced airway hyperresponsiveness in the guinea‐pig: possible involvement of histamine and inflammatory cells

  1993cites this paper
• Endocoids in depression: do antidepressants alter endocoids that affect the serotonergic system?

  1993cites this paper
• The human 5-HT2 receptor is encoded by a multiple intron-exon gene.

  1992cites this paper
• 5‐HT 2 Serotonin Receptor on Blood Platelet of Migraine Patients

  1992cites this paper
• Non-serotonergic 3H-ketanserin binding sites in human platelets: characteristics and interaction with calcium antagonists.

  1992cites this paper
• Dispersion of coronary artery thrombi by antagonism of platelet serotonin receptor in the dog.

  1992cites this paper
• Potentiation of ADP‐induced aggregation in human platelet‐rich plasma by 5‐hydroxytryptamine and adrenaline

  1992cites this paper
• Pharmacological profile of a new 5-hydroxytryptamine2 receptor antagonist, DV-7028.

  1992cites this paper
• The possible role of serotonin 5HT2 receptor antagonism in cardioprotection.

  1992cites this paper
• Platelets and fibrinolysis.

  1991cites this paper
• Identification of non-serotonergic [3H]ketanserin binding sites on human platelets and their role in serotonin release.

  1991cites this paper
• Desensitization and down-regulation of 5-HT2 receptors in P11 cells.

  1991cites this paper
• 5‐Hydroxytryptamine (5‐HT)‐induced shape change in human platelets determined by computerized data acquisition: correlation with [125I]‐iodo LSD binding at 5‐HT2 receptors

  1991cites this paper
• Pharmacological receptors on blood platelets.

  1991cites this paper
• New approaches to antiplatelet therapy

  1991cites this paper
• LY53857, a 5HT2 Receptor Antagonist, Delays Occlusion and Inhibits Platelet Aggregation in a Rabbit Model of Carotid Artery Occlusion

  1991cites this paper
• Cardiac and carotid vascular effects of 5-hydroxyttyptamine-related drugs in the pig

  1991cites this paper
• Amplifying Effects of 5-Hydroxytryptamine on Human Platelets and Signal Transduction

  1990cites this paper
• Receptors for 5-hydroxytryptamine in the cardiovascular system

  1990cites this paper